?Diminished Ovarian Reserve (DOR)??12.
Conditions
Interventions
test group:taking OVAREVIVE II
Sponsors
?Zhejiang Hospital??
Eligibility
Sex/Gender
Female
Age
25 Years to 50 Years
Inclusion criteria
Inclusion criteria: (1)The age of the subjects should be between 25 and 50 years old (inclusive); (2)Menstrual disorders, including infrequent or frequent menstruation, prolonged or shortened menstrual periods, amenorrhea, and irregular menstrual flow. (3)?Biochemical confirmation with anti-Müllerian hormone (AMH) 10 IU/L for two consecutive menstrual cycles.?; (4)?Subjects must fully understand the purpose, procedures, and related requirements of this study, and voluntarily sign an informed consent form to indicate their willingness to participate in the study.??
Exclusion criteria
Exclusion criteria: (1) Pregnant and lactating subjects; (2) Individuals with congenital developmental abnormalities of the reproductive organs, or primary or secondary amenorrhea caused by acquired organic diseases or injuries to the reproductive organs; (3) Individuals who are allergic to multiple drugs or known to be allergic to the components of the study product.?; (4) Have not received relevant treatment, such as the administration of estrogen and progesterone, traditional Chinese medicine, etc., within the past 3 months; (5) Patients with severe cardiovascular, cerebrovascular, or hepatic and renal dysfunction, as well as mental illness; (6) Individuals with a history of or concurrent malignant tumors; (7) Patients deemed unsuitable for participation in the study by the researcher.??
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The improvement of the menstrual cycle;The degree of improvement in menopausal symptom;The improvement of quality of life; | — |
Secondary
| Measure | Time frame |
|---|---|
| serum anti-Müllerian hormone (AMH);Follicle-Stimulating Hormone (FSH);Estradiol (E2);Luteinizing Hormone (LH);B-ultrasound examination of Antral Follicle Count (AFC); | — |
Countries
China
Contacts
Public ContactZhou Jinhong
?Zhejiang Hospital??
Outcome results
None listed